Don’t miss the latest developments in business and finance.

Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Ointment

Image
Capital Market
Last Updated : Jun 24 2016 | 12:28 PM IST

From USFDA

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/ 1 mg per gram, the generic version of Nystatin and Trimacinolone Acetonide Ointment USP, 100,000 units/ 1mg per gram of Taro.

Powered by Capital Market - Live News

More From This Section

First Published: Jun 24 2016 | 10:46 AM IST

Next Story